Full Text View
Tabular View
No Study Results Posted
Related Studies
Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF
This study has been completed.
Study NCT00952237   Information provided by Dartmouth-Hitchcock Medical Center

First Received on August 4, 2009.   Last Updated on July 26, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Multiple Myeloma
Leukemia
Additional conditions recognized in this trial
Amyloidosis
Hodgkin Disease
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms, Plasma Cell
Paraproteinemias
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Metabolic Diseases
Neoplasms
Neoplasms by Histologic Type
Proteostasis Deficiencies
Vascular Diseases
Interventions listed in this trial
GM-CSF
IL-2
Additional drug interventions recognized in this trial
Interleukin-2
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Antineoplastic Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Dartmouth-Hitchcock Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services